Treatment delays and new evidence
Dear BOPA members We are delighted to share two studies that you may be interested in for your practices. The studies outline the impact of treatment delays (i.e. Delays in…
Find out the latest with BOPA, Oncology, and upcoming events
Dear BOPA members We are delighted to share two studies that you may be interested in for your practices. The studies outline the impact of treatment delays (i.e. Delays in…
We would like to share a recent BOPA member publication Pinkie Chambers et al. The impact of inter-cycle treatment delays on 5-year all-cause mortality in early-stage breast cancer: A retrospective…
Wednesday 25th September 2024 13:00 GMT Register for the Session HERE: https://www.bopa.org.uk/webinarsignupform/ We would like to invite you to join our ‘My Research’ sessions. These sessions are delivered…
Urology – Bladder cancer immunotherapy regimens have been updated and added to the CRUK website. A new form for Nivolumab has been added. Revalidation of the remaining regimen specific consent…
The Education and Training Subcommittee are in the process of updating the eLearning content on the BOPA website. As part of this update, we are looking for an experienced pharmacist…
The next episode of Let’s Talk About SACT is Let’s talk about Diffuse Large B Cell Lymphoma (DLBCL). In this episode we are joined by Chris Salmen. We discuss what…
The UK ECRC August 2024 newsletter is now available UK ECRC Newsletter – August 2024 – BOPA
The BOPA SACT Verification Passport team continue to work behind the scenes to update and review content to optimise the use of this e-learning and training platform. We appreciate all…
The BOPA 2024 Executive Committee Election is now open for voting. Thank you to all of our nominees this year – we really appreciate your nominations for the Executive Committee.…
The next episode of Let’s Talk About SACT is Let’s talk about Hyperthermic Intraperitoneal Chemotherapy. In this episode we are joined by Apini Patel. We discuss what hyperthermic intraperitoneal chemotherapy…
We are delighted to share a BOPA EDI publication is now available on line. Equity, diversity, and inclusion in oncology pharmacy practice: Everyone’s business – Pascale Dettwiller, Suhani Ghiya, Jurga…
Dr Shereen Nabhani-Gebara is BOPA’s Vice Chair and she has been awarded Professor of Oncology at Kingston University. Shereen’s Research is dedicated to improving healthcare outcomes using technology and addressing…